Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,489 | 206,325 | 197,811 | 199,693 | 169,795 |
| Marketable Securities | N/A | N/A | 0 | 37,568 | 100,165 |
| TOTAL | $190,510 | $213,873 | $204,799 | $240,372 | $273,996 |
| Non-Current Assets | |||||
| PPE Net | 22,101 | 22,050 | 22,442 | 23,296 | 23,236 |
| Intangibles | 5,548 | 5,548 | 5,548 | 5,548 | 5,548 |
| Other Non-Current Assets | 29,993 | 27,838 | 29,148 | 29,895 | 30,557 |
| TOTAL | $57,642 | $55,436 | $57,138 | $58,739 | $59,341 |
| Total Assets | $248,152 | $269,309 | $261,937 | $299,111 | $333,337 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,000 |
| Accounts payable and accrued liabilities | 3,589 | 8,961 | 3,644 | 4,506 | 2,487 |
| Accrued Expenses | 29,584 | 23,540 | 22,721 | 21,852 | 16,455 |
| TOTAL | $43,918 | $43,335 | $31,797 | $31,999 | $27,789 |
| Non-Current Liabilities | |||||
| Long Term Debt | 57,967 | 29,357 | 29,314 | 29,273 | 26,208 |
| Deferred Revenues | 3,359 | 4,497 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 33,542 | 31,086 | 50,614 | 51,208 | 51,799 |
| TOTAL | $100,532 | $69,763 | $79,983 | $80,536 | $78,062 |
| Total Liabilities | $144,450 | $113,098 | $111,780 | $112,535 | $105,851 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 62,705 | 62,547 | 62,506 | 62,339 | 62,155 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -464,916 | -406,859 | -408,328 | -365,904 | -320,199 |
| Other shareholders' equity | 0 | 0 | 0 | 1 | 15 |
| TOTAL | $103,702 | $156,211 | $150,157 | $186,576 | $227,486 |
| Total Liabilities And Equity | $248,152 | $269,309 | $261,937 | $299,111 | $333,337 |